Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2013 | (FY)Dec 30, 2011 | (FY)Dec 30, 2010 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | -45.83%-3.96M | -93.89%-2.71M | 67.63%-1.4M | -4.32M | 13.48M | 3,227.68%2.84M | -90.74K |
| Other cash income from operating activities | -45.83%-3.96M | -93.89%-2.71M | 67.63%-1.4M | ---4.32M | --13.48M | 3,227.68%2.84M | ---90.74K |
| Cash paid | |||||||
| Operating cash flow | -45.83%-3.96M | -93.89%-2.71M | 67.63%-1.4M | ---4.32M | --13.48M | 3,227.68%2.84M | ---90.74K |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | 38.86%-3.37M | -172.31%-5.51M | -61.84%-2.02M | -1.25M | -16.54M | 34.11%-32.16M | -48.81M |
| Capital expenditure reported | 35.18%-3.32M | -153.21%-5.12M | -61.84%-2.02M | ---1.25M | ---9.99M | -35.15%-16.05M | ---11.88M |
| Net PPE purchase and sale | -1,580.25%-47.8K | ---2.85K | ---- | ---- | ---3.95M | 54.00%-10.11M | ---21.97M |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---2.6M | 60.00%-6M | ---15M |
| Net investment purchase and sale | ---- | ---383.54K | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --45.64K |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | 38.86%-3.37M | -172.31%-5.51M | -61.84%-2.02M | ---1.25M | ---16.54M | 34.11%-32.16M | ---48.81M |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -100.51%-130.86K | 668.39%25.62M | -48.53%3.33M | 6.48M | 3.72M | -26.84%34.3M | 46.88M |
| Net issuance payments of debt | ---- | ---- | 74.40%-231.47K | ---904.23K | --3.75M | -9.35%28.73M | --31.7M |
| Net common stock issuance | ---- | ---- | -51.70%3.57M | --7.38M | ---30.75K | -65.92%5.43M | --15.92M |
| Net other financing activities | -100.51%-130.86K | --25.6M | ---- | ---- | ---- | 68.26%-469.25K | ---1.48M |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -100.51%-130.86K | 668.39%25.62M | -48.53%3.33M | --6.48M | --3.72M | -26.84%34.3M | --46.88M |
| Net cash flow | |||||||
| Beginning cash position | 2,299.71%18.17M | -12.50%757.21K | 7,663.65%865.34K | --11.15K | --3.4M | -28.21%4.11M | --5.72M |
| Current changes in cash | -142.83%-7.45M | 20,109.86%17.4M | -109.59%-86.97K | --907.29K | --649.9K | 347.17%4.98M | ---2.01M |
| Effect of exchange rate changes | 146.46%27.16K | 152.08%11.02K | 60.15%-21.16K | ---53.1K | --14.42K | -188.07%-352.68K | --400.47K |
| End cash Position | -40.87%10.74M | 2,299.71%18.17M | -12.50%757.21K | --865.34K | --4.06M | 112.66%8.73M | --4.11M |
| Free cash from | 6.55%-7.32M | -129.04%-7.84M | 38.59%-3.42M | ---5.57M | ---465.81K | 31.29%-23.32M | ---33.94M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |